One of the biggest bugbears of the contemporary pharmaceutical industry is the spectre of generic competition. All that time and money invested in research and development, protected so briefly, ...

In another move designed to reduce the US' reliance on imported medicines, the FDA has launched a pilot of fast-track reviews for generics tested and made in domestic facilities. According to the ...

Nearly every SaaS product is either integrating AI or planning to do so. However, the term “AI” has become so broad that it’s often misunderstood, especially by non-technical founders. Words like ...